Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test

August 24, 2026Posted inMedical Technology

Roche and Eli Lilly have won FDA clearance for their latest Alzheimer’s disease diagnostic.

Post navigation

Previous Post
triglyceride-glucose-index-linked-to-elevated-blood-pressure-in-us.-teens Triglyceride-Glucose Index Linked to Elevated Blood Pressure in U.S. Teens
Next Post
How Chromosomes Find Their Matching Partners how-chromosomes-find-their-matching-partners

Recent Posts

  • Retrospective aorto-ostial registry finds no significant difference between balloons and stents
  • Reliability-calibrated contrastive learning improves plant leaf recognition
  • 4D virtual cells model drug responses in human cancer cells
  • A comprehensive review on development of texture in automotive-grade medium manganese steel
  • Cross-sectional study maps digital literacy in older coronary heart patients

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top